Microbial Growth in the Suture Thread, After Application of Different Antiseptic Gels in Mandibular Third Molars Extraction

June 14, 2017 updated by: Samuel Rodríguez Zorrilla, University of Santiago de Compostela

Randomized Clinical Trial of Microbial Growth in the Suture Thread, After the Post-surgical Application of Different Antiseptic Gels in Mandibular Third Molars Extraction

This is a randomized clinical trial in which investigators will compare the antimicrobial effect and inducer of cicatrization as well as the degree of postoperative pain in patients who are extracted the lower third molars.

After the surgery, different bioadhesive gels will be applied in the area of the surgical wound and we will evaluate the aforementioned parameters.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Introduction: Surgical removal of the third molars is one of the most frequent procedures in oral surgery. Healing of the wound is initially sought by approximating the edges using a suturing technique. Adherence and microbiological accumulation of the suture during the period that it remains in the mouth, which can serve as a focus for odontogenic infections. The use of oral antiseptics before and after the surgery is an efficient method for microbial reduction. The purposes of this project were to evaluate the microbial growth in the suture thread on different culture means after the post-surgical application of the gels under study, while assessing the intensity of post-surgical pain and the degree of healing of the surgical wound.

Material and methods: It is a randomized and blind clinical trial. 21 patients participated (42 wisdom teeth), who consulted the unit for a surgical tooth extraction for at least the two lower wisdom teeth. The evaluated bioadhesive gels were: Chlorhexidine gel at 0.2 % (Bexident Gel Gingival®), Chlorhexidine gel at 0.2% + Chitosan (Bexident Post®) and hyaluronic acid gel (ODDENT®). A neutral water-based gel without any active ingredients was also used HISPAGEL 200® (Acofarma, Madrid, Spain) as the control agent. An assessment of the post-surgical healing, the microbiological analysis of the suture thread and the post-surgical pain was developed.

Study Type

Interventional

Enrollment (Actual)

21

Phase

  • Phase 4

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 37 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age: between 18 and 39 years.
  • Good general health.
  • Availability during the study.
  • No current odontological treatments or foreseen during the study period.
  • Acceptance and compliance with the prescribed oral hygiene instructions.
  • Agreement to not used mouthwashes or toothpastes with antiseptic agents during the study period.

Exclusion Criteria:

  • Use of antimicrobial mouthwashes or toothpastes during the period during which the suture remains in the mouth.
  • Diabetes.
  • Smoking.
  • Degenerative diseases.
  • Deficient oral health (cavities, periodontal disease, pathologies of the oral mucosa...).
  • Wearing prosthetic or orthodontic devices.
  • Amoxicillin allergy.
  • Pregnant or lactating women.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo gel
The placebo gel is used by all patients on one side of the mouth and serves as a control group.
Drug: Placebo gel
Placebo is the control group treated with a placebo gel.
Other Names:
  • Hyspagel 200
Drug: Clorhexidine gel
Clorhexidine will be compare with placebo, clorhexidine-chitosán and hyaluronic acid bioadhesive gels
Other Names:
  • Bexident encías
Drug: Clorhexidine-Chitosan gel
Clorhexidine-chitosan will be compare with placebo, clorhexidine and hyaluronic acid bioadhesive gels.
Other Names:
  • Bexident Post
Drug: Hyaluronic Acid gel
Hyaluronic acid will be compare with placebo, clorhexidine, clorhexidine-chitosan bioadhesive gels
Other Names:
  • Oddent
Active Comparator: Clorhexidine gel
Chlorhexidine gel is one of three gels used to compare the placebo gel and will be used on the contralateral side to the side assigned as placebo in a third of the participants.
Drug: Placebo gel
Placebo is the control group treated with a placebo gel.
Other Names:
  • Hyspagel 200
Drug: Clorhexidine gel
Clorhexidine will be compare with placebo, clorhexidine-chitosán and hyaluronic acid bioadhesive gels
Other Names:
  • Bexident encías
Drug: Clorhexidine-Chitosan gel
Clorhexidine-chitosan will be compare with placebo, clorhexidine and hyaluronic acid bioadhesive gels.
Other Names:
  • Bexident Post
Drug: Hyaluronic Acid gel
Hyaluronic acid will be compare with placebo, clorhexidine, clorhexidine-chitosan bioadhesive gels
Other Names:
  • Oddent
Active Comparator: Clorhexidine-Chitosan gel
Clorhexidine-chitosan gel is one of three gels used to compare the placebo gel and will be used on the contralateral side to the side assigned as placebo in a third of the participants.
Drug: Placebo gel
Placebo is the control group treated with a placebo gel.
Other Names:
  • Hyspagel 200
Drug: Clorhexidine gel
Clorhexidine will be compare with placebo, clorhexidine-chitosán and hyaluronic acid bioadhesive gels
Other Names:
  • Bexident encías
Drug: Clorhexidine-Chitosan gel
Clorhexidine-chitosan will be compare with placebo, clorhexidine and hyaluronic acid bioadhesive gels.
Other Names:
  • Bexident Post
Drug: Hyaluronic Acid gel
Hyaluronic acid will be compare with placebo, clorhexidine, clorhexidine-chitosan bioadhesive gels
Other Names:
  • Oddent
Active Comparator: Hyaluronic acid gel
Hialuronic acid gel is one of three gels used to compare the placebo gel and will be used on the contralateral side to the side assigned as placebo in a third of the participants.
Drug: Placebo gel
Placebo is the control group treated with a placebo gel.
Other Names:
  • Hyspagel 200
Drug: Clorhexidine gel
Clorhexidine will be compare with placebo, clorhexidine-chitosán and hyaluronic acid bioadhesive gels
Other Names:
  • Bexident encías
Drug: Clorhexidine-Chitosan gel
Clorhexidine-chitosan will be compare with placebo, clorhexidine and hyaluronic acid bioadhesive gels.
Other Names:
  • Bexident Post
Drug: Hyaluronic Acid gel
Hyaluronic acid will be compare with placebo, clorhexidine, clorhexidine-chitosan bioadhesive gels
Other Names:
  • Oddent

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Microbiological growth on suture tread.
Time Frame: Seven days.
Microbiological growth in CFUs on the suture thread after the application of the distinct bioadhesive gels.
Seven days.
Postoperative pain in the operated area.
Time Frame: Seven days.
The researchers will analyze the degree of postoperative pain patients suffered during the first postoperative week by applying one of the gels to be studied in the area of the surgical wound. To make this measurement the visual analogue pain scale will be used.
Seven days.
Degree of healing.
Time Frame: Seven days.

The degree of healing at 7 days after surgery was measured using a visual healing scale consisting of four different levels of healing status:

  1. - Erithymatous surgical zone and with signs of inflammation and infection.
  2. - Erythematous surgical site without signs of infection.
  3. -Surgical zone of normal color and beginning of epithelization.
  4. -Surgical zone of normal color and advanced epithelization.
Seven days.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Santiago de Compostela

Investigators

  • Principal Investigator: Samuel Rodríguez Zorrilla, DDS,MSc, University of Santiago de Compostela

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 20, 2014

Primary Completion (Actual)

July 15, 2014

Study Completion (Actual)

September 10, 2014

Study Registration Dates

First Submitted

May 28, 2017

First Submitted That Met QC Criteria

June 14, 2017

First Posted (Actual)

June 15, 2017

Study Record Updates

Last Update Posted (Actual)

June 15, 2017

Last Update Submitted That Met QC Criteria

June 14, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 001 (NavyGHB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bacterial Growth

Clinical Trials on Placebo gel

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe